Skip to content
ClinCalc Pro
Menu
Short-acting SSRI (premature ejaculation)

Dapoxetine

Brand names: Priligy

Dapoxetine is a short-acting selective serotonin reuptake inhibitor licensed specifically for the on-demand treatment of premature ejaculation in adult men.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

By inhibiting presynaptic serotonin reuptake it enhances serotonergic neurotransmission in the pathways controlling the ejaculatory reflex, thereby delaying ejaculation.

Prescribing in practice

  • It can cause orthostatic hypotension and syncope, so it is contraindicated in significant cardiac disease and patients should be counselled to recognise prodromal symptoms.
  • It is taken only on demand a few hours before anticipated sexual activity rather than continuously.
  • Avoid co-administration with monoamine oxidase inhibitors and other serotonergic drugs because of the risk of serotonin syndrome.

Monitoring

No routine laboratory monitoring is required, but assess cardiovascular status and orthostatic tolerance before and during treatment.

Counselling the patient

  • Take a single dose only when sexual activity is anticipated, not every day.
  • If you feel faint, lie down with your legs raised and avoid situations where fainting could cause injury.
  • Do not combine with recreational drugs or alcohol, which can worsen dizziness.

Evidence & guidelines

Randomised controlled trials demonstrate that dapoxetine increases intravaginal ejaculatory latency time compared with placebo in premature ejaculation.

Reference: BAUS / EAU PE guidelines; SmPC; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.